MDR 4.60% 41.5¢ medadvisor limited

Entitlement Offer, page-6

  1. 527 Posts.
    lightbulb Created with Sketch. 73
    This company has alot of potential a few red flags but plenty of greens as well. I agree management is in need of a slap and the share price is stagnant atm. Digitization of the pharmacy/medicine industry has been on the agenda for years but nothing happens then covid and lockdowns. Image based prescriptions have only just been allowed thats how slow this industry is. This ship is leaving the port, time to jump on board its going to be a long ride but a solid investment. Or it might go to shit.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.